# AMPA Receptor Within the Prelimbic Cortex Regulates Propofol‐Induced Locomotor Sensitization

**Authors:** Chi Pan, Xinyu Mao, Yujie Jiang, Chenchen Jiang, Jiani Qiu, Yantong Zhang, Gang Chen, Mengting Xu, Jun Li, Binbin Wu

PMC · DOI: 10.1111/adb.70078 · Addiction Biology · 2025-07-28

## TL;DR

This study shows that AMPA receptors in the prelimbic cortex control propofol-induced movement changes in rats, suggesting a key role in addiction mechanisms.

## Contribution

The study identifies AMPARs in the prelimbic cortex as critical for propofol-induced locomotor sensitization in rats.

## Key findings

- Optogenetic inhibition of PL glutamatergic neurons reduced propofol-induced locomotor sensitization.
- NBQX pretreatment blocked the effects of propofol on locomotor activity and reduced AMPAR and signaling pathway markers.
- AMPARs in the PL were confirmed to mediate propofol-induced sensitization via the NMDAR-D1R/ERK/CREB pathway.

## Abstract

Propofol is recognized as an addictive substance in both humans and animals. Increasing evidence suggests that the prelimbic cortex (PL) within the medial prefrontal cortex (mPFC), plays an important role in mediating drug addiction. In this study, we trained adult male Sprague–Dawley rats to establish a model of locomotor sensitization (LS). Moreover, optogenetic inhibition of glutamatergic neurons within the PL inhibited the LS of propofol, whereas optogenetic activation of glutamatergic neurons within the PL promoted the LS of propofol. This effect could be blocked by NBQX (a competitive AMPAR antagonist) pretreatment. Subsequently, a microinjection of NBQX (0.25‐1 μg/0.3 μL/site) or saline was administered into the bilateral PL to further examine the impact of AMPARs on the LS of propofol. We found that NBQX pretreatment significantly inhibited both the distance and activity in sensitized rats. The expressions of GluA1 and GluA2 subunits of AMPARs, phosphorylated NR1 subunit of NMDARs, D1Rs, phosphorylated ERK and phosphorylated CREB within mPFC were statistically significantly decreased after NBQX pretreatment, whereas, the expressions of total ERK, total CREB and total NR1 subunit remained unchanged. This evidence verifies the instrumental role of AMPARs within the PL in mediating the LS of propofol, and the NMDAR‐D1R/ERK/CREB signalling pathway may act as a potential mechanism.

In this study, we trained adult male Sprague‐Dawley rats to establish a model of locomotor sensitization (LS). Moreover, optogenetic inhibition of glutamatergic neurons within the PL inhibited the LS of propofol, whereas optogenetic activation of glutamatergic neurons within the PL promoted the LS of propofol, and this effect could be blocked by NBQX (a competitive AMPAR antagonist) pretreatment. This evidence verifies the instrumental role of AMPARs within the PL in mediating the LS of propofol.

## Linked entities

- **Proteins:** GRIA1 (glutamate ionotropic receptor AMPA type subunit 1), GRIA2 (glutamate ionotropic receptor AMPA type subunit 2), GRIN1 (glutamate ionotropic receptor NMDA type subunit 1), EPHB2 (EPH receptor B2), CREB1 (cAMP responsive element binding protein 1)
- **Chemicals:** propofol (PubChem CID 4943), NBQX (PubChem CID 3272524)

## Full-text entities

- **Genes:** Gria1 (glutamate ionotropic receptor AMPA type subunit 1) [NCBI Gene 50592] {aka GluA1, gluR-A}, Ephb1 (Eph receptor B1) [NCBI Gene 24338] {aka Ephb2, Erk, elk}, Creb1 (cAMP responsive element binding protein 1) [NCBI Gene 81646] {aka Creb}, Grin1 (glutamate ionotropic receptor NMDA type subunit 1) [NCBI Gene 24408] {aka GluN1, NMDAR1, NR1}, Gria2 (glutamate ionotropic receptor AMPA type subunit 2) [NCBI Gene 29627] {aka GluA2, GluR-K2, GluR2, gluR-B}
- **Diseases:** LS (MESH:D001523), drug addiction (MESH:D019966)
- **Chemicals:** Propofol (MESH:D015742), NBQX (MESH:C062865)
- **Species:** Rattus norvegicus (brown rat, species) [taxon 10116], Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12302897/full.md

## Figures

7 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12302897/full.md

## References

44 references — full list in the complete paper: https://tomesphere.com/paper/PMC12302897/full.md

---
Source: https://tomesphere.com/paper/PMC12302897